Data evento: 25 giugno 2021
Gilead-sponsored virtual symposium ‘The next chapter in viral hepatitis’.
As the world begins to emerge from a pandemic and the WHO viral hepatitis elimination goals loom, the narrative of viral hepatitis finds itself at a turning point. While the destructive force of COVID-19 has affected all aspects of life, it has also been a catalyst for the simplification of patient care. I’ll be asking a panel of international faculty for their expert opinions on lessons learned from a year of treating patients within restrictions, and insights into how to optimise care as we enter the next chapter in viral hepatitis management.
Patient perspectives will put the spotlight on the physical and mental impact of chronic hepatitis infection at an individual level, while leading physicians will discuss strategies to optimise outcomes and maintain momentum as we strive for viral hepatitis elimination.